NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Buyer: COMMERCIAL MEDICINES UNIT
- End date in notice
- 31 Aug 2017
- Value shown in notice
- £41,000,000Published award value
View record references
- Source
- Contracts Finder
- Award or lot reference
ocds-b5fd17-5411ace5-adc9-11e6-9901-0019b9f3037b / ocds-b5fd17-5411ace5-adc9-11e6-9901-0019b9f3037b-1